Literature DB >> 24282681

A histopathological comparison of different definitions for quantifying in-stent neointimal tissue: implications for the validity of intracoronary ultrasound and optical coherence tomography measurements.

Pedro A Lemos1, Celso K Takimura, Francisco R M Laurindo, Paulo S Gutierrez, Vera D Aiello.   

Abstract

PURPOSE: Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) define neointima as the tissue encompassed between the stent and the lumen boundaries. This approach differs from the gold-standard histopathology, where neointima is traditionally calculated as the tissue between the internal elastic lamina (IEL) and the lumen. We aimed to investigate whether the neointimal assessment using IVUS and OCT-like definitions would correlate with the traditional histopathological quantification of neointima.
METHODS: Histopathological analysis was obtained from a porcine model of 28-day coronary in-stent neointimal proliferation (n=13 bare stents). Traditional histopathology neointimal area (NIHPATH area) was calculated as the lumen area minus the IEL area, while the percent neointimal obstruction was defined as NIHPATH area divided by the IEL area. The IVUS/OCT-like neointima area (NIHIVUS/OCT area) was defined as the lumen area minus the stent area, while the percent neointimal obstruction was defined as NIHIVUS/OCT area divided by the stent area.
RESULTS: The neointimal area as well as the percent obstruction were significantly correlated between histopathology and IVUS/OCT-like definitions (R(2)=0.89 and 0.95 respectively; P<0.01 for both). The average absolute difference between the IVUS/OCT-like and the pathology-like measurements was close to zero, however with a relatively wide dispersion (difference for neointimal area: 0.41 mm(2) [95% CI 1.72 to (-)0.90 mm(2)]; difference for percent neointimal obstruction: 2.5% [95% CI 11.5% to (-)6.5%]).
CONCLUSIONS: The present findings support the use of stent area in replacement to IEL area, as in IVUS & OCT imaging protocols, for the calculation of neointimal parameters in experimental model of restenosis.

Keywords:  Pathology; intravascular ultrasound; optical coherence tomography; restenosis

Year:  2011        PMID: 24282681      PMCID: PMC3839137          DOI: 10.3978/j.issn.2223-3652.2011.10.03

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  9 in total

Review 1.  Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group.

Authors:  Robert S Schwartz; Elazer R Edelman; Andrew Carter; Nicolas Chronos; Campbell Rogers; Keith A Robinson; Ron Waksman; Judah Weinberger; Robert L Wilensky; Donald N Jensen; Bram D Zuckerman; Renu Virmani
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

2.  Accuracy of optical coherence tomography in the evaluation of neointimal coverage after stent implantation.

Authors:  Akira Murata; David Wallace-Bradley; Armando Tellez; Carlos Alviar; Michael Aboodi; Alexander Sheehy; Leslie Coleman; Laura Perkins; Gaku Nakazawa; Gary Mintz; Greg L Kaluza; Renu Virmani; Juan F Granada
Journal:  JACC Cardiovasc Imaging       Date:  2010-01-12

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  Comparing methods of measurement: why plotting difference against standard method is misleading.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1995-10-21       Impact factor: 79.321

5.  Preventive effects of the heparin-coated stent on restenosis in the porcine model.

Authors:  Y K Ahn; M H Jeong; J W Kim; S H Kim; J H Cho; J G Cho; C S Park; S W Juhng; J C Park; J C Kang
Journal:  Catheter Cardiovasc Interv       Date:  1999-11       Impact factor: 2.692

6.  Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation.

Authors:  M Murata; Y Matsubara; K Kawano; T Zama; N Aoki; H Yoshino; G Watanabe; K Ishikawa; Y Ikeda
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

7.  Coronary artery stretch versus deep injury in the development of in-stent neointima.

Authors:  J Gunn; N Arnold; K H Chan; L Shepherd; D C Cumberland; D C Crossman
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

Review 8.  Preclinical restenosis models and drug-eluting stents: still important, still much to learn.

Authors:  Robert S Schwartz; Nicolas A Chronos; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2004-10-06       Impact factor: 24.094

9.  Drug-eluting stents in preclinical studies: updated consensus recommendations for preclinical evaluation.

Authors:  Robert S Schwartz; Elazer Edelman; Renu Virmani; Andrew Carter; Juan F Granada; Greg L Kaluza; Nicolas A F Chronos; Keith A Robinson; Ron Waksman; Judah Weinberger; Gregory J Wilson; Robert L Wilensky
Journal:  Circ Cardiovasc Interv       Date:  2008-10       Impact factor: 6.546

  9 in total
  3 in total

1.  Histological validation of frequency domain optical coherence tomography for the evaluation of neointimal formation after a novel polymer-free sirolimus-eluting stent implantation.

Authors:  Qiang Fu; Hongyu Hu; Wei Chen; Zhixu Tan; Li Li; Dezhao Wang; Buxing Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

2.  'Longitudinal' topics in Cardiovascular Diagnosis and Therapy (CDT).

Authors:  Paul Schoenhagen; Hussain Isma'eel; Ana Olga Mocumbi
Journal:  Cardiovasc Diagn Ther       Date:  2012-06

3.  Analysis of neointima development in flow diverters using optical coherence tomography imaging.

Authors:  Yoshikazu Matsuda; Joonho Chung; Demetrius K Lopes
Journal:  J Neurointerv Surg       Date:  2017-06-07       Impact factor: 5.836

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.